Citrato de cafeína en la apnea del prematuro

objective: evaluate use of the caffeine citrate, in new born premature, to avoid the apnea appearance. method: prospective study with cross-sectional descriptive of 20 new born premature, that by its condition for being premature does more susceptible to present/display neonatal apnea. all of them received caffeine citrate into the general treatment medical. setting: maternity "conception palacios". pediatric service results: in 19 (95 %) of the patients, the evolution was satisfactory (alive) and in 1 (5%) she was bad (deads). in 17 cases (85 %), the apnea disappeared in the first 36 hours post beginning of the treatment. conclusions: the caffeine citrate used in prophylactic form avoids the appearance of the apneas and in therapeutic form, they disappear.